期刊文献+

胆固醇酯转运蛋白基因多态性与他汀类药的调脂效应

下载PDF
导出
摘要 提要:胆固醇酯转运蛋白作为参与细胞胆固醇代谢过程的一个关键成员,其基因的某些单核苷酸多态如TaqIB,I405V,-629C/A,-631C/A,-971G/A等能影响他汀类药对心血管疾病患者血清胆固醇水平的调节作用。表明胆固醇酯转运蛋白基因单核苷酸多态性可能影响他汀类药的调脂效果及冠心病的疗效。
出处 《岭南心血管病杂志》 2007年第5期379-380,共2页 South China Journal of Cardiovascular Diseases
基金 广东省自然科学基金项目(项目编号KZ0409)
  • 相关文献

参考文献13

  • 1[1]LUSIS A J.Atherosclerosis[J].Nature,2000,407 (6801):233-241.
  • 2[2]FIEGENBAUM M,DASILVEIRA F R,VANDER-SAND C R,et al.The role of common variants of ABCB1,CYP3A4,and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment[J].Clin Pharmacol Ther,2005,78(5):551-558.
  • 3[3]CARLQUIST J F,MUHLESTEIN J B,HORNE B D,et al.The cholesteryl ester transfer protein TaqIB gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease[J].Am Heart J,2003,146 (6):1007-1014.
  • 4[4]KUIVENHOVEN J A,JUKEMA J W,ZWINDERMAN A H,et al.The role of a common variant of the cholesteryl ester transfer protein gene in the progression of cornary atherosclerosis.The Regression Growth Evaluation Statin Study Group[J].N Engl J Med,1998,338 (2):86-93.
  • 5[5]Kotake H,Sekikawa A,Tokita Y,et al.Effect of HMG-CoA Reductase Inhibitor on plasma cholesteryl ester transfer protein activity in primary hypercholesterolemia:comparison among CETP/TAQIB genotype subgroups[J].J Atheroscier Thromb,2002,9(5):207-212.
  • 6[6]VANVENROOIJ F V,STOLK R P,BANGA J D,et al.Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes[J].Diabetes Care,2003,26 (4):1216-1223.
  • 7[7]BOEKHOLDT S M,SACKS F M,JUKEMA J W,et al.Cholesteryl ester transfer protein TaqIB variant,high-density lipoprotein cholesteterol levels,cardiovascular risk,and efficacy of pravastatin treafment:individual patient metaanalysis of 13,677 subjects[J].Circulation,2005,111 (3):278-287.
  • 8[8]DE GROOTH G J,ZERBA K E,HUANG S P,et al.The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study:no interaction with the response to parvastatin therapy and no effects on cardiovascular outcome:a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy[J].J Am Coil Cardiol,2004,43 (5):854-857.
  • 9[9]FREEMAN D J,SAMANI N J,WILSON V,et al.A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovacular events in non-smokers in the west of Scotland coronary prevention study[J].Eur Heart J,2003,24(20):1833-1842.
  • 10[10]BLANKENBERG S,RUPPRECHT H J,BICKEL C,et al.Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease[J].J Am Coll Cardiol,2003,41 (11):1983-1989.

二级参考文献6

  • 1Manzoni M, Rollini M.Biosynthesis and biotechnological production of statins by filamentous fungiand application of these cholesterol-lowering drugs.Appl Microbiol Biotechnol 2002;58(5):555-64
  • 2Vaughan CJ, Delanty N.Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999;30(9):1969-73
  • 3Maitland-van der Zee AH, Klungel OH, Stricker BH,et al. Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors.Atherosclerosis 2002;163(2):213-22
  • 4Yamashita S, Hirano K, Sakai N,et al. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.Biochim Biophys Acta 2000; 1529( 1-3):257 -75
  • 5Schafer AJ, Hawkins JR.DNA variation and the future of human genetics.Nat Biotechnol 1998;16(1):33-9
  • 6Kotake H, Sekikawa A, Tokita Y,et al. Effect of HMG-CoA reductase inhibitor on plasma cholesteryl ester transfer protein activity in primary hypercholesterolemia: comparison among CETP/TaqIB genotype subgroups.J Atheroscler Thromb 2002;9(5):207-12

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部